Skip to content

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Client Alerts

Federal Jury Clears Leading Homeopathic Flu Remedy Manufacturer in Class Action Trial

June 2016

Client Alerts

Federal Jury Clears Leading Homeopathic Flu Remedy Manufacturer in Class Action Trial

June 2016

On June 16, in a class action of importance to producers, marketers, and sellers of homeopathic products, a federal jury in the false advertising trial of Lewert v. Boiron, Inc., et al., Case No. 2:11-cv-10803 (Boiron) rejected claims that Boiron Inc.’s homeopathic flu treatment was nothing more than a sugar pill, and ruled that Boiron did not mislead consumers into buying a remedy that did not provide relief as advertised.

Read the Client Alert here.

ADDITIONAL INFORMATION

For more information, please contact:

This Client Alert has been prepared by Tucker Ellis LLP for the use of our clients. Although prepared by professionals, it should not be used as a substitute for legal counseling in specific situations. Readers should not act upon the information contained herein without professional guidance.

Related News

Five Practical Tips for Successful Settlement Negotiations

Karen E. Ross, published in OACTA Quarterly Review More